Popular drugs for diabetes and weight loss could have an unexpected side effect. Glucagon-like peptide 1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked ...
Headlines warning about “Ozempic blindness” may be frightening to the millions of people taking a GLP-1 drug to treat Type 2 diabetes or for weight loss. It's not an official diagnosis, but an ...
Hosted on MSN
Ozempic Side Effects: Active Ingredeints Found In Weight Loss Drugs Linked To Rare But Serious Eye Problems
Been using a weight loss drug or thinking of starting one? A new study has found that popular diabetes and weight loss drugs like Ozempic and Mounjaro can increase the risk of certain eye problems.
Share on Pinterest New research links GLP-1 medications such as semaglutide and tirzepatide to a doubled risk of potentially blinding eye diseases. Javier Zayas Photography/Getty Images The most ...
ROANOKE, Va. (WDBJ) - As GLP-1 medications continue to grow in popularity for weight loss, a group of eye doctors is urging caution about potential risks to vision. GLP-1 medications were first used ...
Glucagon-like peptide-1 receptor agonist drugs (commonly referred to as GLP-1 agonists) have become widely prescribed for type 2 diabetes and weight loss. Medications such as Ozempic, Wegovy, Mounjaro ...
Verywell Health on MSN
What causes eye miosis (constricted pupils)
Medically reviewed by Christine L. Larsen, MD Key Takeaways Medications, trauma, and medical conditions can cause miosis or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results